The immunological and virological consequences of planned treatment interruptions in children with HIV infection

The immunological and virological consequences of planned treatment interruptions in children with HIV infection

Objectives To evaluate the immunological and viral consequences of planned treatment interruptions (PTI) in children with HIV. Design This was an immunological and virological sub-study of the Paediatric European Network for Treatment of AIDS (PENTA) 11 trial, which compared CD4-guided PTI of antire...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Klein, N, Sefe, D, Mosconi, I, Zanchetta, M, Castro, H, Jacobsen, M, Jones, H, Bernardi, S, Pillay, D, Giaquinto, C, Walker, A, Gibb, D, De Rossi, A
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Public Library of Science 2013

Gelijkaardige items

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
door: Touloumi, G, et al.
Gepubliceerd in: (2006)

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.
door: Touloumi, G, et al.
Gepubliceerd in: (2008)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
door: Fidler, S, et al.
Gepubliceerd in: (2002)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
door: Fidler, S, et al.
Gepubliceerd in: (2002)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
door: Gossez, M, et al.
Gepubliceerd in: (2018)

Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy.
door: Zanchetta, M, et al.
Gepubliceerd in: (2006)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.
door: Vasiliver-Shamis, G, et al.
Gepubliceerd in: (2010)

Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
door: Lewis, J, et al.
Gepubliceerd in: (2012)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
door: Hurst, J, et al.
Gepubliceerd in: (2015)

Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection.
door: Gibb, D, et al.
Gepubliceerd in: (2004)

Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia.
door: Kaye, S, et al.
Gepubliceerd in: (2008)

Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
door: Bienczak, A, et al.
Gepubliceerd in: (2016)

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
door: Prendergast, A, et al.
Gepubliceerd in: (2008)

Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.
door: Jallow, S, et al.
Gepubliceerd in: (2006)

Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children.
door: Burger, D, et al.
Gepubliceerd in: (2004)

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
door: Green, H, et al.
Gepubliceerd in: (2007)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
door: Lewis, J, et al.
Gepubliceerd in: (2017)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
door: Szubert, A, et al.
Gepubliceerd in: (2017)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
door: Kekitiinwa, A, et al.
Gepubliceerd in: (2017)

Identification of the phenotypic, genotypic and fitness correlates of non-B subtype HIV-1 NRTI resistance through longitudinal analysis of children with virological failure in the developing world
door: Mbisa, J, et al.
Gepubliceerd in: (2010)

Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
door: Phillips, A, et al.
Gepubliceerd in: (2004)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
door: Munderi, P, et al.
Gepubliceerd in: (2010)

Virologic response to first-line efavirenz- or nevirapine-based anti-retroviral therapy in HIV-infected African children
door: Kekitiinwa, A, et al.
Gepubliceerd in: (2017)

Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
door: De Rossi, A, et al.
Gepubliceerd in: (2005)

Treatment interruption in chronic HIV-1 infection: does it deliver?
door: Willberg, C, et al.
Gepubliceerd in: (2007)

Baseline adherence, socio-demographic, clinical, immunological, virological and anthropometric characteristics of 242 HIV positive patients on ART in Malaysia
door: Abiola, Abdulrahman Surajudeen, et al.
Gepubliceerd in: (2015)

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation
door: Ogbenna, AA, et al.
Gepubliceerd in: (2019)

Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial.
door: Pillay, D, et al.
Gepubliceerd in: (2002)

Virological and immunological outcomes in rhesus monkeys after exposure to dengue virus–infected Aedes aegypti mosquitoes
door: Carrington, LB, et al.
Gepubliceerd in: (2020)

Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
door: De Rossi, A, et al.
Gepubliceerd in: (2002)

Immunology of viral co-infections with HIV.
door: Northfield, J, et al.
Gepubliceerd in: (2005)

BMT306 – Virology [Virologi]
door: PPSKJ, Pusat Pengajian Sains Kajihayat
Gepubliceerd in: (2023)

Dynamics of accumulation of drug resistance mutations in the absence of virological monitoring in HIV-1-infected Zambian children using adult Triomune (fixed-dose combination d4T, 3TC and NVP)
door: Gupta, R, et al.
Gepubliceerd in: (2009)

A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.
door: Green, H, et al.
Gepubliceerd in: (2006)

Homocysteine modification of HLA antigens and its immunological consequences.
door: Gao, X, et al.
Gepubliceerd in: (1996)

Monitoring of highly active antiretroviral therapy in HIV infection.
door: Walker, A, et al.
Gepubliceerd in: (2011)

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD)
door: Oyomopito, R., et al.
Gepubliceerd in: (2010)

The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK.
door: Donegan, K, et al.
Gepubliceerd in: (2012)

HIV-1 DNA predicts disease progression and post-treatment virological control.
door: Williams, J, et al.
Gepubliceerd in: (2014)

Fundamentals of molecular virology /
door: 314302 Acheson, N. H.
Gepubliceerd in: (2007)